MERUS N V's ticker is MRUS and the CUSIP is N5749R100. A total of 68 filers reported holding MERUS N V in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $87,977 | -18.6% | 3,731 | -9.1% | 0.05% | -17.2% |
| Q2 2023 | $108,032 | -19.6% | 4,103 | -43.8% | 0.06% | -13.5% |
| Q1 2023 | $134,412 | -14.0% | 7,305 | -27.7% | 0.07% | -9.8% |
| Q4 2022 | $156,340 | +48.9% | 10,106 | +93.6% | 0.08% | +95.2% |
| Q3 2022 | $105,000 | -10.3% | 5,220 | +0.7% | 0.04% | -2.3% |
| Q2 2022 | $117,000 | -19.9% | 5,183 | -6.0% | 0.04% | -33.8% |
| Q1 2022 | $146,000 | -21.5% | 5,513 | -5.6% | 0.06% | -7.1% |
| Q4 2021 | $186,000 | -10.1% | 5,843 | -37.8% | 0.07% | -23.1% |
| Q3 2021 | $207,000 | -0.5% | 9,391 | -4.9% | 0.09% | +5.8% |
| Q2 2021 | $208,000 | – | 9,876 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 1,600,000 | $33,712,000 | 6.04% |
| BVF INC/IL | 7,285,071 | $153,496,000 | 5.75% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 320,815 | $6,760,000 | 3.02% |
| Burrage Capital Management LLC | 130,683 | $2,753,000 | 2.76% |
| MPM BioImpact LLC | 700,879 | $14,768,000 | 2.43% |
| Boxer Capital, LLC | 1,900,000 | $40,033,000 | 1.41% |
| Octagon Capital Advisors LP | 206,927 | $4,360,000 | 0.90% |
| DAFNA Capital Management LLC | 157,841 | $3,326,000 | 0.70% |
| Ghost Tree Capital, LLC | 75,000 | $1,580,000 | 0.43% |
| SPHERA FUNDS MANAGEMENT LTD. | 286,506 | $6,037,000 | 0.41% |